Lineage Cell Therapeutics, Inc. (LCTX) Stock Price History
Historical prices from 1992 to 2026
- 1M
- +7.8%
- 3M
- -13.7%
- YTD
- -19.5%
- 1Y
- +38.9%
- 3Y
- -1.2%
- 5Y
- -13.4%
Loading 10-year price history...
LCTX Historical Performance
LCTX Annual Returns
Year-by-year price performance · 2002–2026
- 2002 annual price return
- -66.5%
- 2003 annual price return
- -15.3%
- 2004 annual price return
- +4.9%
- 2005 annual price return
- -79.5%
- 2006 annual price return
- -15.6%
- 2007 annual price return
- +57.7%
- 2008 annual price return
- +365.8%
- 2009 annual price return
- +141.7%
- 2010 annual price return
- +76.1%
- 2011 annual price return
- -34.9%
- 2012 annual price return
- -48.7%
- 2013 annual price return
- +8.8%
- 2014 annual price return
- +2.5%
- 2015 annual price return
- +4.1%
- 2016 annual price return
- -1.9%
- 2017 annual price return
- -40.9%
- 2018 annual price return
- -60.3%
- 2019 annual price return
- -14.4%
- 2020 annual price return
- +101.4%
- 2021 annual price return
- +26.9%
- 2022 annual price return
- -52.8%
- 2023 annual price return
- -11.4%
- 2024 annual price return
- -53.9%
- 2025 annual price return
- +224.3%
- 2026 annual price return
- +17.1%
LCTX Stock Price Trajectory (1992–2026)
As of July 8, 2026, Lineage Cell Therapeutics, Inc. (LCTX) trades at $1.32, representing a +38.9% return over the past year. The stock has delivered a -51.3% total return over five years (-13.4% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $27.00 on October 31, 1997. From this peak, LCTX has corrected -95.1%, currently trading 17% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers FATE (+184.9% 1Y), NTLA (+70.0% 1Y), and BEAM (+97.7% 1Y), LCTX has underperformed the peer group average. Compare LCTX vs FATE →
LCTX Historical Price Data · from 1992
Rows 1–50 of 8,645| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-07-07 | 1.34 | 1.34 | 1.29 | 1.32 | 673K | -0.75% |
| 2026-07-06 | 1.35 | 1.38 | 1.32 | 1.33 | 835K | -1.48% |
| 2026-07-02 | 1.31 | 1.36 | 1.29 | 1.35 | 711K | +3.85% |
| 2026-07-01 | 1.33 | 1.33 | 1.29 | 1.30 | 766K | -0.76% |
| 2026-06-30 | 1.33 | 1.37 | 1.30 | 1.31 | 819K | -2.96% |
| 2026-06-29 | 1.29 | 1.36 | 1.29 | 1.35 | 1.43M | +5.47% |
| 2026-06-26 | 1.23 | 1.30 | 1.20 | 1.28 | 16.46M | +4.92% |
| 2026-06-25 | 1.26 | 1.28 | 1.20 | 1.22 | 1.14M | -2.40% |
| 2026-06-24 | 1.27 | 1.28 | 1.25 | 1.25 | 776K | 0.00% |
| 2026-06-23 | 1.26 | 1.29 | 1.24 | 1.25 | 722K | -0.79% |
| 2026-06-22 | 1.24 | 1.27 | 1.22 | 1.26 | 1.51M | +4.13% |
| 2026-06-18 | 1.26 | 1.29 | 1.21 | 1.21 | 1.45M | -2.02% |
| 2026-06-17 | 1.23 | 1.27 | 1.22 | 1.24 | 967K | 0.00% |
| 2026-06-16 | 1.24 | 1.26 | 1.23 | 1.24 | 1.19M | -0.80% |
| 2026-06-15 | 1.29 | 1.32 | 1.23 | 1.25 | 131K | -1.97% |
| 2026-06-12 | 1.28 | 1.30 | 1.26 | 1.27 | 1.02M | -0.78% |
| 2026-06-11 | 1.22 | 1.29 | 1.22 | 1.28 | 890K | +4.07% |
| 2026-06-10 | 1.23 | 1.25 | 1.20 | 1.23 | 1.28M | +0.82% |
| 2026-06-09 | 1.20 | 1.26 | 1.18 | 1.22 | 1.39M | -0.41% |
| 2026-06-08 | 1.23 | 1.25 | 1.19 | 1.23 | 1.07M | +2.94% |
| 2026-06-05 | 1.24 | 1.24 | 1.19 | 1.19 | 979K | -1.65% |
| 2026-06-04 | 1.18 | 1.26 | 1.18 | 1.21 | 685K | +0.83% |
| 2026-06-03 | 1.20 | 1.23 | 1.19 | 1.20 | 801K | -0.83% |
| 2026-06-02 | 1.21 | 1.25 | 1.19 | 1.21 | 1.69M | -3.97% |
| 2026-06-01 | 1.33 | 1.36 | 1.26 | 1.26 | 364K | -5.26% |
| 2026-05-29 | 1.33 | 1.36 | 1.31 | 1.33 | 541K | 0.00% |
| 2026-05-28 | 1.30 | 1.36 | 1.29 | 1.33 | 922K | +0.76% |
| 2026-05-27 | 1.31 | 1.35 | 1.30 | 1.32 | 655K | +2.33% |
| 2026-05-26 | 1.32 | 1.34 | 1.27 | 1.29 | 1.23M | -0.77% |
| 2026-05-22 | 1.33 | 1.36 | 1.28 | 1.30 | 23K | -1.52% |
| 2026-05-21 | 1.26 | 1.33 | 1.26 | 1.32 | 584K | +2.33% |
| 2026-05-20 | 1.20 | 1.32 | 1.20 | 1.29 | 1.92M | +7.50% |
| 2026-05-19 | 1.22 | 1.27 | 1.20 | 1.20 | 1.11M | -3.23% |
| 2026-05-18 | 1.24 | 1.26 | 1.21 | 1.24 | 1.45M | -0.80% |
| 2026-05-15 | 1.26 | 1.28 | 1.23 | 1.25 | 1.06M | -4.58% |
| 2026-05-14 | 1.27 | 1.35 | 1.25 | 1.31 | 2.04M | +0.77% |
| 2026-05-13 | 1.34 | 1.35 | 1.22 | 1.30 | 1.71M | -2.26% |
| 2026-05-12 | 1.32 | 1.35 | 1.28 | 1.33 | 1.67M | +0.76% |
| 2026-05-11 | 1.36 | 1.43 | 1.31 | 1.32 | 1.61M | -3.65% |
| 2026-05-08 | 1.38 | 1.40 | 1.35 | 1.37 | 1.16M | 0.00% |
| 2026-05-07 | 1.44 | 1.45 | 1.36 | 1.37 | 1.50M | -4.20% |
| 2026-05-06 | 1.49 | 1.49 | 1.41 | 1.43 | 801K | -2.05% |
| 2026-05-05 | 1.46 | 1.50 | 1.45 | 1.46 | 1.17M | +2.82% |
| 2026-05-04 | 1.50 | 1.52 | 1.40 | 1.42 | 2.76M | -7.19% |
| 2026-05-01 | 1.50 | 1.55 | 1.49 | 1.53 | 1.36M | +1.32% |
| 2026-04-30 | 1.47 | 1.52 | 1.46 | 1.51 | 1.79M | +3.42% |
| 2026-04-29 | 1.57 | 1.58 | 1.46 | 1.46 | 2.27M | -6.41% |
| 2026-04-28 | 1.54 | 1.66 | 1.53 | 1.56 | 1.30M | +0.65% |
| 2026-04-27 | 1.57 | 1.60 | 1.54 | 1.55 | 612K | 0.00% |
| 2026-04-24 | 1.57 | 1.58 | 1.54 | 1.55 | 807K | -0.64% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
LCTX — Frequently Asked Questions
Quick answers to the most common questions about buying LCTX stock.
How has LCTX stock performed recently?
LCTX returned +38.9% over the past year, beating its 5-year annualized CAGR of -13.4%. The stock trades below its 200-day moving average, confirming the uptrend.
What is LCTX's all-time high price?
Lineage Cell Therapeutics, Inc. reached $27.00 on 1997-10-31. The 52-week high is $2.09. Current 1-year return of +38.9% places the stock closer to historical peaks.
Where can I download LCTX historical price data?
This page provides LCTX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 1992-2026, downloadable in CSV format.